支气管上皮细胞CC16 mRNA低表达与哮喘严重程度相关
该研究在重度哮喘研究计划中分析242例哮喘患者和69例对照者支气管上皮细胞CC16 mRNA表达,发现低表达与哮喘易感性、严重程度、口服激素使用、急性发作及肺功能下降显著相关,并与T2炎症生物标志物升高相关,提示CC16是潜在的非传统T2生物标志物。
要点
- 支气管上皮细胞CC16 mRNA低表达与哮喘易感性和严重程度显著相关。
- 低CC16 mRNA表达与口服激素使用、急性和前瞻性急性发作及肺功能下降相关。
- CC16联合IL-6可区分四种具有不同T2炎症、肥胖和严重程度特征的哮喘内型。
核心结论
- 支气管上皮细胞CC16 mRNA低表达与哮喘易感性、严重程度和急性发作相关,部分通过免疫调节T2炎症实现。
- CC16是哮喘发生和进展的潜在非传统T2生物标志物。
研究设计与样本
- 研究纳入重度哮喘研究计划中242例哮喘患者和69例对照者。
- 采用广义线性模型分析支气管上皮细胞CC16 mRNA表达水平与哮喘相关表型的关联。
主要发现
- 低CC16 mRNA表达水平与哮喘易感性和哮喘严重程度显著相关。
- 低CC16 mRNA表达水平与高系统性糖皮质激素使用、高回顾性和前瞻性哮喘急性发作及低肺功能显著相关。
- 低CC16 mRNA表达水平与高T2炎症生物标志物(呼出气一氧化氮分数和痰嗜酸性粒细胞)显著相关。
- CC16 mRNA表达水平与Th2基因(IL1RL1、POSTN、SERPINB2、CLCA1、NOS2和MUC5AC)表达水平呈负相关,与Th1和炎症基因(IL12A和MUC5B)表达水平呈正相关。
- CC16和IL-6两种非传统T2生物标志物组合揭示四种具有不同T2炎症、肥胖和哮喘严重程度特征的哮喘内型。
临床怎么用
- CC16 mRNA表达水平可作为评估哮喘易感性、严重程度和急性发作风险的潜在生物标志物。
- CC16联合IL-6有助于识别具有不同T2炎症、肥胖和严重程度特征的哮喘内型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: CC16 is a protein mainly produced by nonciliated bronchial epithelial cells (BECs) that participates in host defense. Reduced CC16 protein concentrations in BAL and serum are associated with asthma susceptibility. Objectives: Few studies have investigated the relationship between CC16 and asthma progression, and none has focused on BECs. In this study, we sought to determine if CC16 mRNA expression levels in BECs are associated with asthma severity. Methods: Association analyses between CC16 mRNA expression levels in BECs (242 asthmatics and 69 control subjects) and asthma-related phenotypes in Severe Asthma Research Program were performed using a generalized linear model. Measurements and Main Results: Low CC16 mRNA expression levels in BECs were significantly associated with asthma susceptibility and asthma severity, high systemic corticosteroids use, high retrospective and prospective asthma exacerbations, and low pulmonary function. Low CC16 mRNA expression levels were significantly associated with high T2 inflammation biomarkers (fractional exhaled nitric oxide and sputum eosinophils). CC16 mRNA expression levels were negatively correlated with expression levels of Th2 genes (IL1RL1, POSTN, SERPINB2, CLCA1, NOS2, and MUC5AC) and positively correlated with expression levels of Th1 and inflammation genes (IL12A and MUC5B). A combination of two nontraditional T2 biomarkers (CC16 and IL-6) revealed four asthma endotypes with different characteristics of T2 inflammation, obesity, and asthma severity. Conclusions: Our findings indicate that low CC16 mRNA expression levels in BECs are associated with asthma susceptibility, severity, and exacerbations, partially through immunomodulation of T2 inflammation. CC16 is a potential nontraditional T2 biomarker for asthma development and progression.
引用
- Li X, Guerra S, Ledford JG, et al. Low CC16 mRNA Expression Levels in Bronchial Epithelial Cells Are Associated with Asthma Severity. Am J Respir Crit Care Med. 2023. PMID: 36066606. doi:10.1164/rccm.202206-1230OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。